IDXX Annual Current Liabilities
$951.55 M
-$284.26 M-23.00%
31 December 2023
Summary:
As of January 22, 2025, IDXX annual total current liabilities is $951.55 million, with the most recent change of -$284.26 million (-23.00%) on December 31, 2023. During the last 3 years, it has risen by +$368.79 million (+63.28%). IDXX annual current liabilities is now -23.00% below its all-time high of $1.24 billion, reached on December 31, 2022.IDXX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Quarterly Current Liabilities
$1.01 B
-$107.48 M-9.62%
30 September 2024
Summary:
As of January 22, 2025, IDXX quarterly total current liabilities is $1.01 billion, with the most recent change of -$107.48 million (-9.62%) on September 30, 2024. Over the past year, it has increased by +$39.03 million (+4.02%). IDXX quarterly current liabilities is now -18.33% below its all-time high of $1.24 billion, reached on December 31, 2022.IDXX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.0% | +4.0% |
| 3 y3 years | +63.3% | -18.3% |
| 5 y5 years | +23.5% | -18.3% |
IDXX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.0% | +24.6% | -18.3% | +32.2% |
| 5 y | 5-year | -23.0% | +63.3% | -18.3% | +91.6% |
| alltime | all time | -23.0% | >+9999.0% | -18.3% | >+9999.0% |
IDEXX Laboratories Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.01 B(-9.6%) |
| June 2024 | - | $1.12 B(+16.7%) |
| Mar 2024 | - | $956.90 M(+0.6%) |
| Dec 2023 | $951.55 M(-23.0%) | $951.55 M(-1.9%) |
| Sept 2023 | - | $970.19 M(+9.8%) |
| June 2023 | - | $883.86 M(-17.1%) |
| Mar 2023 | - | $1.07 B(-13.8%) |
| Dec 2022 | $1.24 B(+61.8%) | $1.24 B(+3.9%) |
| Sept 2022 | - | $1.19 B(+2.0%) |
| June 2022 | - | $1.17 B(+20.1%) |
| Mar 2022 | - | $971.34 M(+27.2%) |
| Dec 2021 | $763.58 M(+31.0%) | $763.58 M(+20.5%) |
| Sept 2021 | - | $633.85 M(-2.8%) |
| June 2021 | - | $651.81 M(+5.0%) |
| Mar 2021 | - | $620.66 M(+6.5%) |
| Dec 2020 | $582.76 M(-19.7%) | $582.76 M(+10.6%) |
| Sept 2020 | - | $526.84 M(-2.5%) |
| June 2020 | - | $540.58 M(-36.1%) |
| Mar 2020 | - | $846.24 M(+16.7%) |
| Dec 2019 | $725.34 M(-5.9%) | $725.34 M(+15.8%) |
| Sept 2019 | - | $626.63 M(+1.2%) |
| June 2019 | - | $618.91 M(-10.3%) |
| Mar 2019 | - | $689.62 M(-10.5%) |
| Dec 2018 | $770.44 M(-23.3%) | $770.44 M(+1.4%) |
| Sept 2018 | - | $759.54 M(-1.9%) |
| June 2018 | - | $774.32 M(+6.2%) |
| Mar 2018 | - | $728.84 M(-27.4%) |
| Dec 2017 | $1.00 B(+7.5%) | $1.00 B(+0.8%) |
| Sept 2017 | - | $996.54 M(-0.5%) |
| June 2017 | - | $1.00 B(+7.0%) |
| Mar 2017 | - | $936.08 M(+0.2%) |
| Dec 2016 | $934.57 M(+9.1%) | $934.57 M(+22.9%) |
| Sept 2016 | - | $760.21 M(-7.6%) |
| June 2016 | - | $822.78 M(-6.4%) |
| Mar 2016 | - | $878.67 M(+2.6%) |
| Dec 2015 | $856.76 M(+4.4%) | $856.76 M(+3.9%) |
| Sept 2015 | - | $824.77 M(+6.4%) |
| June 2015 | - | $775.43 M(-3.5%) |
| Mar 2015 | - | $803.45 M(-2.1%) |
| Dec 2014 | $820.91 M(+71.6%) | $820.91 M(+30.2%) |
| Sept 2014 | - | $630.26 M(+5.0%) |
| June 2014 | - | $600.35 M(+16.1%) |
| Mar 2014 | - | $517.17 M(+8.1%) |
| Dec 2013 | $478.35 M(+17.7%) | $478.35 M(-19.3%) |
| Sept 2013 | - | $592.95 M(+7.5%) |
| June 2013 | - | $551.67 M(+25.5%) |
| Mar 2013 | - | $439.58 M(+8.2%) |
| Dec 2012 | $406.33 M(-7.0%) | $406.33 M(-2.3%) |
| Sept 2012 | - | $415.85 M(-0.8%) |
| June 2012 | - | $419.15 M(-4.1%) |
| Mar 2012 | - | $437.28 M(+0.1%) |
| Dec 2011 | $436.88 M(+53.2%) | $436.88 M(+29.9%) |
| Sept 2011 | - | $336.37 M(+12.8%) |
| June 2011 | - | $298.14 M(+9.4%) |
| Mar 2011 | - | $272.57 M(-4.4%) |
| Dec 2010 | $285.11 M(+11.2%) | $285.11 M(+5.2%) |
| Sept 2010 | - | $270.93 M(-0.1%) |
| June 2010 | - | $271.20 M(-6.2%) |
| Mar 2010 | - | $289.17 M(+12.8%) |
| Dec 2009 | $256.31 M(-13.2%) | $256.31 M(+29.1%) |
| Sept 2009 | - | $198.56 M(-6.8%) |
| June 2009 | - | $213.11 M(-27.1%) |
| Mar 2009 | - | $292.14 M(-1.1%) |
| Dec 2008 | $295.29 M(+32.2%) | $295.29 M(-4.0%) |
| Sept 2008 | - | $307.75 M(+2.9%) |
| June 2008 | - | $299.05 M(+12.8%) |
| Mar 2008 | - | $265.03 M(+18.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $223.39 M(+79.1%) | $223.39 M(+6.8%) |
| Sept 2007 | - | $209.17 M(-2.1%) |
| June 2007 | - | $213.57 M(+13.4%) |
| Mar 2007 | - | $188.41 M(+51.0%) |
| Dec 2006 | $124.74 M(+17.1%) | $124.74 M(+6.9%) |
| Sept 2006 | - | $116.73 M(-5.3%) |
| June 2006 | - | $123.32 M(+25.4%) |
| Mar 2006 | - | $98.37 M(-7.7%) |
| Dec 2005 | $106.57 M(+6.6%) | $106.57 M(+9.3%) |
| Sept 2005 | - | $97.52 M(+4.6%) |
| June 2005 | - | $93.25 M(+9.6%) |
| Mar 2005 | - | $85.05 M(-14.9%) |
| Dec 2004 | $99.95 M(-0.4%) | $99.95 M(+6.4%) |
| Sept 2004 | - | $93.98 M(+5.5%) |
| June 2004 | - | $89.05 M(+2.8%) |
| Mar 2004 | - | $86.60 M(-13.7%) |
| Dec 2003 | $100.34 M(+42.8%) | $100.34 M(+14.1%) |
| Sept 2003 | - | $87.96 M(-0.2%) |
| June 2003 | - | $88.17 M(+13.3%) |
| Mar 2003 | - | $77.81 M(+10.7%) |
| Dec 2002 | $70.27 M(-1.5%) | $70.27 M(-22.9%) |
| Sept 2002 | - | $91.12 M(+29.7%) |
| June 2002 | - | $70.25 M(-13.4%) |
| Mar 2002 | - | $81.10 M(+13.6%) |
| Dec 2001 | $71.38 M(-3.6%) | $71.38 M(-3.6%) |
| Sept 2001 | - | $74.02 M(+11.1%) |
| June 2001 | - | $66.62 M(+1.8%) |
| Mar 2001 | - | $65.44 M(-11.6%) |
| Dec 2000 | $74.05 M(+0.6%) | $74.05 M(-15.8%) |
| Sept 2000 | - | $87.96 M(+1.1%) |
| June 2000 | - | $87.04 M(+19.2%) |
| Mar 2000 | - | $72.99 M(-0.9%) |
| Dec 1999 | $73.64 M(-1.2%) | $73.64 M(+4.9%) |
| Sept 1999 | - | $70.20 M(-7.0%) |
| June 1999 | - | $75.50 M(+15.1%) |
| Mar 1999 | - | $65.60 M(-11.9%) |
| Dec 1998 | $74.50 M(+0.3%) | $74.50 M(+27.8%) |
| Sept 1998 | - | $58.30 M(-18.6%) |
| June 1998 | - | $71.60 M(+3.8%) |
| Mar 1998 | - | $69.00 M(-7.1%) |
| Dec 1997 | $74.30 M(+45.4%) | $74.30 M(+6.1%) |
| Sept 1997 | - | $70.00 M(+25.7%) |
| June 1997 | - | $55.70 M(+13.0%) |
| Mar 1997 | - | $49.30 M(-3.5%) |
| Dec 1996 | $51.10 M(+53.0%) | $51.10 M(+7.4%) |
| Sept 1996 | - | $47.60 M(-4.8%) |
| June 1996 | - | $50.00 M(+39.7%) |
| Mar 1996 | - | $35.80 M(+7.2%) |
| Dec 1995 | $33.40 M(+51.8%) | $33.40 M(+4.4%) |
| Sept 1995 | - | $32.00 M(-3.3%) |
| June 1995 | - | $33.10 M(+8.9%) |
| Mar 1995 | - | $30.40 M(+38.2%) |
| Dec 1994 | $22.00 M(+53.8%) | $22.00 M(-2.2%) |
| Sept 1994 | - | $22.50 M(-0.4%) |
| June 1994 | - | $22.60 M(+18.9%) |
| Mar 1994 | - | $19.00 M(+32.9%) |
| Dec 1993 | $14.30 M(+52.1%) | $14.30 M(+2.1%) |
| Sept 1993 | - | $14.00 M(+12.9%) |
| June 1993 | - | $12.40 M(+10.7%) |
| Mar 1993 | - | $11.20 M(+19.1%) |
| Dec 1992 | $9.40 M(+42.4%) | $9.40 M(+3.3%) |
| Sept 1992 | - | $9.10 M(-7.1%) |
| June 1992 | - | $9.80 M(+4.3%) |
| Mar 1992 | - | $9.40 M(+42.4%) |
| Dec 1991 | $6.60 M | $6.60 M(+1.5%) |
| Sept 1991 | - | $6.50 M(-4.4%) |
| June 1991 | - | $6.80 M |
FAQ
- What is IDEXX Laboratories annual total current liabilities?
- What is the all time high annual current liabilities for IDEXX Laboratories?
- What is IDEXX Laboratories annual current liabilities year-on-year change?
- What is IDEXX Laboratories quarterly total current liabilities?
- What is the all time high quarterly current liabilities for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly current liabilities year-on-year change?
What is IDEXX Laboratories annual total current liabilities?
The current annual current liabilities of IDXX is $951.55 M
What is the all time high annual current liabilities for IDEXX Laboratories?
IDEXX Laboratories all-time high annual total current liabilities is $1.24 B
What is IDEXX Laboratories annual current liabilities year-on-year change?
Over the past year, IDXX annual total current liabilities has changed by -$284.26 M (-23.00%)
What is IDEXX Laboratories quarterly total current liabilities?
The current quarterly current liabilities of IDXX is $1.01 B
What is the all time high quarterly current liabilities for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly total current liabilities is $1.24 B
What is IDEXX Laboratories quarterly current liabilities year-on-year change?
Over the past year, IDXX quarterly total current liabilities has changed by +$39.03 M (+4.02%)